Syn Stock Forecast Zacks
P/b ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. We should also highlight that pag has a p/b ratio.
The stock has been a strong.
Syn stock forecast zacks. Synaptics (syna) came out with quarterly earnings of $2.68 per share, beating the zacks consensus estimate of $2.62 per share. Synaptics stock has undergone multiple analysts rating changes in the recent past. The lowest sales estimate is $341.90 million and.
Right now, syna is averaging 419,825 shares for the last 20 days. View synaptics incorporated syna investment & stock information. Shares of synaptics (syna) have been strong performers lately, with the stock up 52.5% over the past month.
While the stock has been a strong performer lately,. This suggests a possible upside of 536.3% from the stock's current price. Their forecasts range from $175.00 to $310.00.
This compares to earnings of. Each stock is a zacks rank #1 strong buy. The p/b is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.
On average, they expect synthetic biologics' share price to reach $2.50 in the next twelve months. See the report's 7 new picks today. Synaptics (syna) could be a solid choice for investors given the company's remarkably improving earnings outlook.
The zacks momentum style score encompasses many things, including estimate revisions and a stock's price movement. Wall street brokerages expect synaptics incorporated (nasdaq:syna) to announce $379.50 million in sales for the current quarter, according to zacks. Pag is currently sporting a zacks rank of #1 (strong buy), as well as a value grade of a.
Investors should note that earnings estimates are also significant to the zacks rank, and a nice path here can be promising. Given these factors, it shouldn't be surprising that syna is a #2 (buy) stock and boasts a momentum score of a. 114 rows syn earnings information.
Their forecasts range from $2.50 to $2.50. Synaptics (syna) delivered earnings and revenue surprises of 2.29% and 0.34%, respectively, for the quarter ended september 2021. By zacks equity research published on november 04,2021.
Price to book value per share ratio. Two analysts have issued estimates for synaptics' earnings. One stock to keep an eye on is penske automotive (pag).
Investors should note that earnings estimates are also. Both asx and syna are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that asx is the superior value option. Another notable valuation metric for simo is its p/b ratio of 3.43.
On average, they expect synaptics' stock price to reach $233.33 in the next year. This suggests that the stock has a possible downside of 18.4%. In a note to investors, the firm issued a new rating of hold.
The analysts previously had rating of buy. Synaptics (syna) appears an attractive pick given a noticeable improvement in the company's earnings outlook. Synnovia has a p/b ratio of 1.61.
The zacks momentum style score encompasses many things, including estimate revisions and a stock's price movement. Synthetic biologics last announced its quarterly.
Komentar
Posting Komentar